← FDA DRUG APPROVALS

FDA ANDA · ANDA071295

ATROPINE

Sponsor: ABBVIE

APPLICATION
ANDA071295
TYPE
ANDA
ORIGINAL APPROVAL
1987-01-30
LATEST ACTION
1991-01-16
ROUTE
INTRAMUSCULAR
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

ATROPINEDiscontinued
ATROPINE EQ 2MG SULFATE/0.7ML · SOLUTION · INTRAMUSCULAR

Approval history

1991-01-16Labeling · Supplement 7AP
1991-01-16Manufacturing (CMC) · Supplement 6AP
1989-01-11Manufacturing (CMC) · Supplement 5AP
1988-07-26Labeling · Supplement 4AP
1988-06-10Manufacturing (CMC) · Supplement 2AP
1988-06-10Labeling · Supplement 3AP
1987-03-25Manufacturing (CMC) · Supplement 1AP
1987-01-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →